Back

Acylcarnitines as early predictors of 10-year diabetes risk in a population-based apparently healthy cohort

23 April 2026 (08:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Predicting and managing diabetes-associated cardiovascular risk Biomarkers Delegates Premium Access ESC Preventive Cardiology 2026 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Doctor Ko Ko Maung

University Hospital Centre Vaudois (CHUV), Lausanne (Switzerland)

6 More presentations in this session

Presentation thumbnail
Protein-protein interaction network construction and analysis to identify synergistic effects for sodium-glucose cotransporter-2, glucagon-like peptide-1 and mineralocorticoid receptor
Professor G. Tse (Hong Kong, CN)
Abstract Slides
Presentation thumbnail
Bridging guidelines to practice: digital health platform identifies central adiposity as dominant driver of insulin resistance in real-world prevention settings
Doctor B. Jiravska Godula (Trinec, CZ)
Abstract Slides
Presentation thumbnail
Patient-reported experiences with icosapent ethyl in adults with type 2 diabetes: Insights from a UK primary care survey
Mrs M. Donaldson (Louth, GB)
Abstract Slides
Presentation thumbnail
Impact of gestational diabetes on maternal lipid profile and cardiac biomarkers
Mr M. Oneto Fernandez (Puerto Real, ES)
Presentation thumbnail
Multiblock proteomic profiling of the molecular link between prediabetes and preclinical atherosclerosis in apparently healthy adults
Doctor N. Zieleniewska (Bialystok, PL)
Abstract Slides

Access the full session

Session thumbnail
Predicting and managing diabetes-associated cardiovascular risk

The Event

Event poster

ESC Preventive Cardiology 2026

23 April - 25 April 2026
You may be interested in
thumbnail
Congress Presentation
Advancements and challenges in cardiovascular risk stratification: an overview of cardiac biomarkers
thumbnail
Webinar
Biomarkers of clinical utility in cardiovascular disease
thumbnail
Congress Session
Challenges and innovations in cardiovascular risk stratification with cardiac biomarkers

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources